Company
Treace Medical Concepts
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
21
510(k), De Novo and PMA
Device trials
4
As lead sponsor, any status
Adverse event reports
323
Received Nov 1, 2025 to Nov 21, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
TMCI
Nasdaq · TREACE MEDICAL CONCEPTS, INC.
Public float
$266M
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$213M
Fiscal year ending Dec 31, 2025
Net income
-$59.0M
Fiscal year ending Dec 31, 2025
R&D spending
$20.3M
Fiscal year ending Dec 31, 2025
Cash
$7.8M
As of Sep 30, 2026
Long-term debt
$56.3M
As of Sep 30, 2026
Shares outstanding
65.6M
As of Oct 30, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2023 | $108M | – | – | – |
| 2021 | $108M | – | – | – |
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| May 1, 2017 | Equity | $5.9M | $5.9M | 38 | Rule 506(b) | Form D ↗May 10, 2017 |
2 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- TREACE MEDICAL CONCEPTS, INC.
- Headquarters
- Ponte Vedra Beach, Florida
- Incorporated
- Delaware in 2014
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1630627 ↗
Executives, directors and promoters
As listed on the latest Form D.
8 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
The investor database is free with an account
Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.
Latest FDA decisions
The 8 newest of 21 since 2015.
K262963 · Decided Sep 15, 2026 · 21 days after receipt
Device type: Plate, Fixation, Bone (HRS) · Orthopedic Surgery
20 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT05082012 · 123 participants · Start Sep 17, 2021 · Primary completion May 9, 2024
Device: Treatment of Hallux Valgus · For: Hallux Valgus; Bunion
Sites: Decatur, Alabama; Hartselle, Alabama; Scottsdale, Arizona · 10 sites in all
3 more trials with a free account
Reports received
323
Received Nov 1, 2025 to Nov 21, 2026
Malfunction reports
9
2.8% of reports
Injury reports
314
97% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 8 | 33 | 0 | 0 |
| Jan 24 | 1 | 26 | 0 | 0 |
| Feb 24 | 1 | 9 | 0 | 0 |
| Mar 24 | 3 | 15 | 0 | 0 |
| Apr 24 | 0 | 24 | 0 | 0 |
| May 24 | 1 | 15 | 0 | 0 |
| Jun 24 | 0 | 21 | 0 | 0 |
| Jul 24 | 5 | 17 | 0 | 0 |
| Aug 24 | 0 | 17 | 0 | 0 |
| Sep 24 | 1 | 19 | 0 | 0 |
| Oct 24 | 2 | 17 | 0 | 0 |
| Nov 24 | 0 | 35 | 0 | 0 |
| Dec 24 | 5 | 9 | 0 | 0 |
| Jan 25 | 1 | 9 | 0 | 0 |
| Feb 25 | 2 | 5 | 0 | 0 |
| Mar 25 | 1 | 13 | 0 | 0 |
| Apr 25 | 0 | 10 | 0 | 0 |
| May 25 | 0 | 9 | 0 | 0 |
| Jun 25 | 4 | 13 | 0 | 0 |
| Jul 25 | 0 | 10 | 0 | 0 |
| Aug 25 | 0 | 13 | 0 | 0 |
| Sep 25 | 0 | 11 | 0 | 0 |
| Oct 25 | 1 | 14 | 0 | 0 |
| Nov 25 | 1 | 5 | 0 | 0 |
| Dec 25 | 1 | 18 | 0 | 0 |
| Jan 26 | 1 | 14 | 0 | 0 |
| Feb 26 | 0 | 18 | 0 | 0 |
| Mar 26 | 1 | 34 | 0 | 0 |
| Apr 26 | 0 | 31 | 0 | 0 |
| May 26 | 0 | 37 | 0 | 0 |
| Jun 26 | 2 | 37 | 0 | 0 |
| Jul 26 | 0 | 27 | 0 | 0 |
| Aug 26 | 1 | 27 | 0 | 0 |
| Sep 26 | 0 | 38 | 0 | 0 |
| Oct 26 | 2 | 28 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
The full in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Nanoplasty 3D Bunion Correction System Implant, Model Number: SK57. System contains the 01-00066 1st Metatarsal Plate as a component.Open, Classified
Z-2718-2024 · Started Jun 2, 2024 · Posted by FDA Aug 23, 2024
Reason given: Potential issue causing a higher frequency of interference with locking screws and/or inserter rods than anticipated, resulting in screws stripping and/or not fully seating in the plates and/or interface issues between inserter rods and plates.
Cause as FDA categorized it: Under Investigation by firm · Device type: Plate, Fixation, Bone (HRS)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.